⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KYTX News
Kyverna Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
KYTX
Form 8-K
sec.gov
KYTX
Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
globenewswire.com
KYTX
Kyverna Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
KYTX
Form 8-K
sec.gov
KYTX
Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results
globenewswire.com
KYTX
Form 8-K
sec.gov
KYTX
Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer
globenewswire.com
KYTX
Form 8-K
sec.gov
KYTX
Form 8-K
sec.gov
KYTX